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x Endocarditis occurring ^60 days after surgery is described as early prosthetic valve endocarditis and is primarily related to bacteremia associated with indwelling vascular catheters or perioperative infection; offending organisms are most commonly Staphylococcus aureus, S. epidermidis, and diptheroids. Endocarditis occurring >60 days after valve replacement is described as late prosthetic valve endocarditis and is related to bacteremia associated with minor surgery, skin infections, dental procedures, or a variety of gastrointestinal and genitourinary tract procedures; offending organisms are most commonly Staphylococcus spp. and Streptococcus spp. 1 We review the type and incidence of neurologic complications among patients with late prosthetic valve endocarditis, examine the influence of these neurologic complications on mortality, and seek to identify the subsets of patients at risk.
Subjects and Methods
We reviewed the records of patients who had a diagnosis of endocarditis and were referred to the Division of Infectious Disease at the University of Iowa Hospitals between January 1985 and June 1988. Criteria for the diagnosis of late prosthetic valve endocarditis included at least three of the following: 1) fever, 2) new regurgitant murmur, 3) evidence of peripheral emboli, 4) two or more blood cultures growing the same organism, and 5) direct evidence of valve infection at autopsy or surgery. We excluded patients diagnosed s60 days after surgery. We reviewed the cases to determine the incidence and type of neurologic complications defined as intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), cerebral infarction, or transient ischemic attack (TTA). Diagnosis of the types of cerebrovascular event were based on the clinical criteria developed for the Harvard Cooperative Stroke Registry, 2 and for the diagnosis of TIA we used the definition of the Classification and Outline of Cerebrovascular Disease. 
Staph

Results
We identified 107 cases of infective endocarditis during the study period; 20 (14 men and six women) met the criteria for late prosthetic valve endocarditis. These 20 patients are the subject of this review (Table 1) . Their ages ranged from 20 to 80 (average 57.9) years. All 20 patients had a single valve replacement procedure. The site of valve replacement was mitral in seven, aortic in 12, and tricuspid in one patient. Eleven valves were mechanical, and the other nine were bioprosthetic. Staphylococcus spp. were the infecting organism in 10 patients. One patient had culture-negative endocarditis; the diagnosis was made histopathologically at surgery. Echocardiography was performed in 12 patients; vegetations were found in one, who did not have a neurologic complication. Nine patients (45%) died.
Of the 20 patients, eight had neurologic complications (Table 2) . Cerebral infarction occurred in four patients; three had an ICH. In one patient infarction was associated with SAH, and one patient had a transient episode of aphasia. Seven patients were on anticoagulants at the time of presentation, six were on warfarin and one was on heparin. Prothrombin time was not available in three of these seven patients prior to admission (cases 2, 7, and 9). Mortality was 50% (four of eight).
Discussion
Patients with prosthetic valves have a number of medical or neurologic complications, including prosthetic valve endocarditis. Previous reports give similar estimates of the incidence of neurologic complications for both early and late prosthetic valve endocarditis, in the range of 25-30%. 4 -7 When nonspecific symptoms such as headache and encephalopathy are included, the incidence of neurologic complications may be as high as 40%. 8 Patients with prosthetic valve endocarditis have a high mortality. The presence of paravalvular leak, infection with other than Streptococcus spp., and moderateto-severe congestive heart failure portend a particularly poor prognosis. 6 Overall mortality in our series was 45%, similar to that previously reported, 6 -9 - 14 and mortality among our patients with neurologic complications was 50%; all three patients with ICH died. Among 13 patients with late prosthetic valve endocarditis and central nervous system complications, Karchmer et al 6 found a mortality of 69% (nine of 13). Among 48 patients with early and late prosthetic valve endocarditis, Masur and Johnson 5 found 15 with neurologic complications; eight of these 15 patients died, one of ICH and seven of hemiparesis followed by coma and death.
Cerebrovascular events are the most common neurologic complication in patients with late prosthetic valve endocarditis. Ischemic stroke was the most common neurologic complication in our series; it occurred in four patients and was fatal in one. The presumed mechanism of ischemic stroke in each case •Multiple thromboemboli found at autopsy.
was emboli arising from the infected valves. The rate of embolization from infected valves depends on the underlying coagulation status of the patient and the administration of antibiotics. Without anticoagulants, embolization rates approach 50% 15 ; with adequate anticoagulant therapy, the incidence drops to 3-14%. 16 Davenport et al 17 reported a daily stroke rate ranging from 1% to 9% depending on the infecting organism, falling to almost 0% after institution of appropriate antibiotics.
ICH accounted for three fatal neurologic complications among our eight patients. Two hemorrhages were intraparenchymal and the other was subarachnoid. Characteristics of the patients with ICH included 1) prior anticoagulant use with prothrombin times 1.3-2.0 times control, 2) mechanical prostheses in the mitral position, and 3) infection with Staphylococcus aureus (two of three patients). Previous series 613 ' 18 have also found that ICH carries a grave prognosis.
Because of the risk of ICH, the use of anticoagulants in the context of an infected cardiac valve remains controversial.
18 " 20 In a review of 17 patients with both native and prosthetic valve endocarditis, Hart et al 21 postulated three mechanisms of ICH: 1) sterile embolic events causing bland infarction and subsequent hemorrhagic transformation, 2) septic emboli resulting in acute erosive arteritis, and 3) septic emboli occurring during adequate antibiotic therapy resulting in aneurysm formation. Anticoagulant therapy has been reported to decrease the frequency of thromboembolism and to significantly decrease mortality in patients with prosthetic valve endocarditis. Although we agree with Wilson et al, 19 who recommended that once ICH occurs anticoagulants be stopped, we believe that after 48-72 hours, anticoagulants can be cautiously restarted. No further studies in the last 10 years have answered the question of whether the risk of anticoagulation justifies the prevention of further embolic events in these patients.
SAH, which may be the initial manifestation of infective endocarditis, 22 occurred in only one of our patients. Karchmer et al 6 also found a case of SAH thought to be secondary to septic vasculitis.
Mycotic aneurysm is a rare complication of infective endocarditis. 23 Angiography in four patients failed to show mycotic aneurysm. Although cerebral hemorrhage is often presumed to be secondary to aneurysm rupture, the incidence of angiographicalry demonstrated mycotic aneurysm (approximately 1.8%) is much lower than the incidence of hemorrhage. 24 Multiple microemboli may present with solely mental status changes. One patient in our series developed a presumed "toxic encephalopathy" without lateralizing signs. Computed tomograms and cerebrospinal fluid examinations were repeatedly normal. He died of ongoing sepsis. Autopsy revealed multiple sterile cerebral microemboli.
A number of conclusions can be drawn from our experience: 1) neurologic complications are a frequent cause of morbidity and mortality among patients with late prosthetic valve endocarditis, 2) mortality is higher among patients with neurologic complications, 3) patients with neurologic complications are more likely to have a mechanical valve in the mitral position, and 4) early recognition and treatment of late prosthetic valve endocarditis is needed as mortality remains high.
